Mindfulness as a complementary intervention in the treatment of overweight and obesity in primary health care: study protocol for a randomised controlled trial

Table 1 Overview of measures and corresponding measurement time points

Measure	Target concept	Baseline	T1	T2
BES	Binge eating	x	x	x
BPAAT	Physical activity	x	x	x
DEBQ	Food style	x	x	x
EAT-26	Presence of abnormal eating patterns	x	x	x
HADS	Anxiety and depression symptoms	x	x	x
MAAS	Mindfulness skills	x	x	x
FFQ	Food Frequency Questionnaire	x	x	x
SCS	Self-compassion	x	x	x
Transtheoretical Model	Behaviour change	x	x	x
Feasibility Questionnaire	Feasibility of intervention		x
Adverse effects questionnaire	Occurrence adverse effects		x	x
Amount of weekly practices	Adherence to practice		x	x
Anthropometry	Change in weight	x	x	x
Basal metabolic rate	Basal metabolism	x	x	x
Body composition	Fat mass and lean mass	x	x	x
BDNF	Brain-derived neurotrophic factor	x	x	x
Cortisol serum	Stress	x	x	x
Fasting blood glucose	Glycaemic control	x	x	x
HbA1c	Haemoglobin A1c	x	x	x
Insulin	Insulin	x	x	x
US-CRP	Ultra-sensitive C-reactive protein	x	x	x
Total cholesterol, fractions and TGL	Lipid profile	x	x	x
Alpha-1-glycoprotein	Inflammatory process	x	x	x
Focus group	Qualitative analysis		x	x

Abbreviations: BES Binge Eating Scale, BPAAT Brief Physical Activity Assessment Tool, DEBQ Dutch Food Behaviour Questionnaire, EAT-26 Eating Attitude Test, FFQ Food Frequency Questionnaire, HADS Hospital Anxiety and Depression Scale HbA1c glycated haemoglobin, MAAS Mindful Attention Awareness Scale, SCS Self-Compassion Scale, T1 8 or 10 weeks post-intervention (TAU, TAU + MBHP, TAU + MB-EAT), T2 3 months post-intervention (TAU, TAU + MBHP, TAU + MB-EAT), US-CRP Ultra-sensitive C-reactive protein, BDNF Brain-derived neurotrophic factor, TGL Triglycerides

ISSN: 1745-6215